Commonwealth Equity Services’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,180
| Closed | -$182K | – | 4048 |
|
|
2023
Q3 | $182K | Sell |
10,180
-1,325
| -12% | -$23.7K | ﹤0.01% | 3412 |
|
|
2023
Q2 | $237K | Sell |
11,505
-2,619
| -19% | -$54K | ﹤0.01% | 3247 |
|
|
2023
Q1 | $288 | Sell |
14,124
-427
| -3% | -$9 | ﹤0.01% | 3006 |
|
|
2022
Q4 | $325K | Sell |
14,551
-403
| -3% | -$9K | ﹤0.01% | 2808 |
|
|
2022
Q3 | $310K | Sell |
14,954
-1,769
| -11% | -$36.7K | ﹤0.01% | 2799 |
|
|
2022
Q2 | $388K | Buy |
16,723
+497
| +3% | +$11.5K | ﹤0.01% | 2611 |
|
|
2022
Q1 | $444K | Sell |
16,226
-692
| -4% | -$18.9K | ﹤0.01% | 2621 |
|
|
2021
Q4 | $602K | Buy |
16,918
+222
| +1% | +$7.9K | ﹤0.01% | 2369 |
|
|
2021
Q3 | $684K | Sell |
16,696
-1,012
| -6% | -$41.5K | ﹤0.01% | 2233 |
|
|
2021
Q2 | $708K | Sell |
17,708
-3,431
| -16% | -$137K | ﹤0.01% | 2189 |
|
|
2021
Q1 | $750K | Buy |
21,139
+3,480
| +20% | +$123K | ﹤0.01% | 2023 |
|
|
2020
Q4 | $549K | Buy |
17,659
+2,006
| +13% | +$62.4K | ﹤0.01% | 2096 |
|
|
2020
Q3 | $432K | Buy |
+15,653
| New | +$432K | ﹤0.01% | 2068 |
|